C. Robert Horsburgh, MD
Professor, Global Health
Biography
Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Departments of Epidemiology, Biostatistics, Global Health and Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS, the Epidemiology of Tuberculosis and Vaccine Epidemiology. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, South Africa, Tanzania, Vietnam and the Philippines. He is the Vice-President of the International Union Against Tuberculosis and Lung Disease (IUATLD) and Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials and dissemination of best practices (www.resisttb.org).
Other Positions
- Professor, Epidemiology, Boston University School of Public Health
- Professor, Infectious Diseases, Medicine, Boston University Chobanian & Avedisian School of Medicine
- Professor, Biostatistics, Boston University School of Public Health
- Boston Medical Center
Education
- Case Western Reserve University, MD
- Yale University, MS
- Princeton University, AB
Publications
- Published on 9/22/2023
Pei PP, Fitzmaurice KP, Le MH, Panella C, Jones ML, Pandya A, Horsburgh CR, Freedberg KA, Weinstein MC, Paltiel AD, Reddy KP. The Value-of-Information and Value-of-Implementation from Clinical Trials of Diagnostic Tests for HIV-Associated Tuberculosis: A Modeling Analysis. MDM Policy Pract. 2023; 8(2):23814683231198873. PMID: 37743931.
Read at: PubMed - Published on 9/1/2023
Rodriguez CA, Leavitt SV, Bouton TC, Horsburgh CR, Zur Wiesch PA, Nichols B, Jenkins HE, White LF. Survival of people with untreated TB: effects of time, geography and setting. Int J Tuberc Lung Dis. 2023 Sep 01; 27(9):694-702. PMID: 37608480.
Read at: PubMed - Published on 8/30/2023
Swartwood NA, Testa C, Cohen T, Marks SM, Hill AN, Beeler Asay G, Cochran J, Cranston K, Randall LM, Tibbs A, Horsburgh CR, Salomon JA, Menzies NA. Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States. BMC Med. 2023 Aug 30; 21(1):331. PMID: 37649031.
Read at: PubMed - Published on 8/28/2023
Kalva J, Babu SP, Narasimhan PB, Raghupathy K, Ezhumalai K, Knudsen S, Horsburgh CR, Hochberg N, Salgame P, Roy G, Ellner J, Sarkar S. Predictors of weight loss during the intensive phase of tuberculosis treatment in patients with drug-susceptible pulmonary tuberculosis in South India. J Public Health (Oxf). 2023 Aug 28; 45(3):545-552. PMID: 36451280.
Read at: PubMed - Published on 8/1/2023
Acuña-Villaorduña C, Jacobson KR, Horsburgh CR, Canning M, Sinha P. Initial experience with BPaL-based regimens to treat multidrug-resistant TB. Int J Tuberc Lung Dis. 2023 Aug 01; 27(8):649-650. PMID: 37491751.
Read at: PubMed - Published on 7/28/2023
Hu Z, Liu K, Zhou M, Jiang X, Feng Y, Yu Z, Li Y, Chen S, Wu Q, Wang W, Horsburgh CR, Zhang Y, Zhou L, Chen B, Hu C, Martinez L. Mass tuberculosis screening among the elderly: A population-based study in a well-confined rural county in eastern China. Clin Infect Dis. 2023 Jul 28. PMID: 37506258.
Read at: PubMed - Published on 7/22/2023
Motta I, Boeree M, Chesov D, Dheda K, Günther G, Horsburgh CR, Kherabi Y, Lange C, Lienhardt C, McIlleron HM, Paton NI, Stagg HR, Thwaites G, Udwadia Z, Van Crevel R, Velásquez GE, Wilkinson RJ, Guglielmetti L. Recent advances in the treatment of tuberculosis. Clin Microbiol Infect. 2023 Jul 22. PMID: 37482332.
Read at: PubMed - Published on 7/3/2023
Esmail H, Coussens AK, Thienemann F, Sossen B, Mukasa SL, Warwick J, Goliath RT, Davies NO, Douglass E, Jackson A, Lakay F, Streicher E, Munro JE, Barrios MH, Heinsohn T, Macpherson L, Sheerin D, Aziz S, Serole K, Daroowala R, Taliep A, Ahlers P, Malherbe ST, Bowden R, Warren R, Walzl G, Via LE, Bahlo M, Jacobson KR, Horsburgh CR, Salgame P, Alland D, Barry CE, Flynn JL, Ellner JJ, Wilkinson RJ. High resolution imaging and five-year tuberculosis contact outcomes. medRxiv. 2023 Jul 03. PMID: 37461515.
Read at: PubMed - Published on 7/1/2023
Martinez L, Warren JL, Harries AD, Croda J, Espinal MA, Olarte RAL, Avedillo P, Lienhardt C, Bhatia V, Liu Q, Chakaya J, Denholm JT, Lin Y, Kawatsu L, Zhu L, Horsburgh CR, Cohen T, Andrews JR. Global, regional, and national estimates of tuberculosis incidence and case detection among incarcerated individuals from 2000 to 2019: a systematic analysis. Lancet Public Health. 2023 Jul; 8(7):e511-e519. PMID: 37393090.
Read at: PubMed - Published on 6/15/2023
Burman W, Fox GJ, Horsburgh CR. Treatment Strategy for Rifampin-Susceptible Tuberculosis. N Engl J Med. 2023 Jun 15; 388(24):2296-2297. PMID: 37314714.
Read at: PubMed
View 352 more publications: View full profile at BUMC